abstract |
HIF1A mRNA for treating ocular neovascularization, especially those with retinal edema, diabetic retinopathy, sequelae associated with retinal ischemia, posterior neovascularization (PSNV) and neovascular glaucoma and patients at risk of developing these symptoms. RNA interference for expression inhibition is provided. |